CD14 and melanoma: Next, we investigated the frequency of the immune regulatory cell subsets present in the peripheral blood of melanoma patients prior to survivin-specific vaccination; for this analysis, we focussed on Th17 cells, Tregs and CD14+HLA-DR- MDSC.